Global Pharma Contract Manufacturing Organisations (Cmos) Market Report 2019, Competitive Landscape, Trends and Opportunities
The Pharma Contract Manufacturing Organisations (Cmos) market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Pharma Contract Manufacturing Organisations (Cmos) market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Pharma Contract Manufacturing Organisations (Cmos) market.
Major players in the global Pharma Contract Manufacturing Organisations (Cmos) market include:
Almac Group
Boehringer Ingelheim
Patheon Inc.
WuXi AppTec
Grifols International, S.A
Lonza AG
Vetter
Pharmaceutical Product Development
AbbVie Inc
CMIC Group
Nectar Lifesciences
Catalant
Aenova Group
On the basis of types, the Pharma Contract Manufacturing Organisations (Cmos) market is primarily split into:
Active Pharmaceutical Ingredient (API) Manufacturing
Finished Dosage Formulation (FDF) Market
On the basis of applications, the market covers:
Pharma company
Biotech company
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Pharma Contract Manufacturing Organisations (Cmos) market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Pharma Contract Manufacturing Organisations (Cmos) market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Pharma Contract Manufacturing Organisations (Cmos) industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Pharma Contract Manufacturing Organisations (Cmos) market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Pharma Contract Manufacturing Organisations (Cmos), by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Pharma Contract Manufacturing Organisations (Cmos) in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Pharma Contract Manufacturing Organisations (Cmos) in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Pharma Contract Manufacturing Organisations (Cmos). Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Pharma Contract Manufacturing Organisations (Cmos) market, including the global production and revenue forecast, regional forecast. It also foresees the Pharma Contract Manufacturing Organisations (Cmos) market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
The report mainly studies the size, recent trends and development status of the Pharma Contract Manufacturing Organisations (Cmos) market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Pharma Contract Manufacturing Organisations (Cmos) market.
Major players in the global Pharma Contract Manufacturing Organisations (Cmos) market include:
Almac Group
Boehringer Ingelheim
Patheon Inc.
WuXi AppTec
Grifols International, S.A
Lonza AG
Vetter
Pharmaceutical Product Development
AbbVie Inc
CMIC Group
Nectar Lifesciences
Catalant
Aenova Group
On the basis of types, the Pharma Contract Manufacturing Organisations (Cmos) market is primarily split into:
Active Pharmaceutical Ingredient (API) Manufacturing
Finished Dosage Formulation (FDF) Market
On the basis of applications, the market covers:
Pharma company
Biotech company
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Pharma Contract Manufacturing Organisations (Cmos) market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Pharma Contract Manufacturing Organisations (Cmos) market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Pharma Contract Manufacturing Organisations (Cmos) industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Pharma Contract Manufacturing Organisations (Cmos) market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Pharma Contract Manufacturing Organisations (Cmos), by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Pharma Contract Manufacturing Organisations (Cmos) in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Pharma Contract Manufacturing Organisations (Cmos) in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Pharma Contract Manufacturing Organisations (Cmos). Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Pharma Contract Manufacturing Organisations (Cmos) market, including the global production and revenue forecast, regional forecast. It also foresees the Pharma Contract Manufacturing Organisations (Cmos) market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
1 PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) MARKET OVERVIEW
1.1 Product Overview and Scope of Pharma Contract Manufacturing Organisations (Cmos)
1.2 Pharma Contract Manufacturing Organisations (Cmos) Segment by Type
1.2.1 Global Pharma Contract Manufacturing Organisations (Cmos) Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Active Pharmaceutical Ingredient (API) Manufacturing
1.2.3 The Market Profile of Finished Dosage Formulation (FDF) Market
1.3 Global Pharma Contract Manufacturing Organisations (Cmos) Segment by Application
1.3.1 Pharma Contract Manufacturing Organisations (Cmos) Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Pharma company
1.3.3 The Market Profile of Biotech company
1.4 Global Pharma Contract Manufacturing Organisations (Cmos) Market by Region (2014-2026)
1.4.1 Global Pharma Contract Manufacturing Organisations (Cmos) Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.3 Europe Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.3.1 Germany Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.3.2 UK Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.3.3 France Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.3.4 Italy Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.3.5 Spain Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.3.6 Russia Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.3.7 Poland Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.4 China Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.5 Japan Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.6 India Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.8 Central and South America Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Pharma Contract Manufacturing Organisations (Cmos) (2014-2026)
1.5.1 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue Status and Outlook (2014-2026)
1.5.2 Global Pharma Contract Manufacturing Organisations (Cmos) Production Status and Outlook (2014-2026)
2 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) MARKET LANDSCAPE BY PLAYER
2.1 Global Pharma Contract Manufacturing Organisations (Cmos) Production and Share by Player (2014-2019)
2.2 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue and Market Share by Player (2014-2019)
2.3 Global Pharma Contract Manufacturing Organisations (Cmos) Average Price by Player (2014-2019)
2.4 Pharma Contract Manufacturing Organisations (Cmos) Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Pharma Contract Manufacturing Organisations (Cmos) Market Competitive Situation and Trends
2.5.1 Pharma Contract Manufacturing Organisations (Cmos) Market Concentration Rate
2.5.2 Pharma Contract Manufacturing Organisations (Cmos) Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Almac Group
3.1.1 Almac Group Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.1.3 Almac Group Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.1.4 Almac Group Business Overview
3.2 Boehringer Ingelheim
3.2.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.2.3 Boehringer Ingelheim Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.2.4 Boehringer Ingelheim Business Overview
3.3 Patheon Inc.
3.3.1 Patheon Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.3.3 Patheon Inc. Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.3.4 Patheon Inc. Business Overview
3.4 WuXi AppTec
3.4.1 WuXi AppTec Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.4.3 WuXi AppTec Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.4.4 WuXi AppTec Business Overview
3.5 Grifols International, S.A
3.5.1 Grifols International, S.A Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.5.3 Grifols International, S.A Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.5.4 Grifols International, S.A Business Overview
3.6 Lonza AG
3.6.1 Lonza AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.6.3 Lonza AG Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.6.4 Lonza AG Business Overview
3.7 Vetter
3.7.1 Vetter Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.7.3 Vetter Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.7.4 Vetter Business Overview
3.8 Pharmaceutical Product Development
3.8.1 Pharmaceutical Product Development Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.8.3 Pharmaceutical Product Development Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.8.4 Pharmaceutical Product Development Business Overview
3.9 AbbVie Inc
3.9.1 AbbVie Inc Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.9.3 AbbVie Inc Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.9.4 AbbVie Inc Business Overview
3.10 CMIC Group
3.10.1 CMIC Group Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.10.3 CMIC Group Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.10.4 CMIC Group Business Overview
3.11 Nectar Lifesciences
3.11.1 Nectar Lifesciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.11.3 Nectar Lifesciences Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.11.4 Nectar Lifesciences Business Overview
3.12 Catalant
3.12.1 Catalant Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.12.3 Catalant Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.12.4 Catalant Business Overview
3.13 Aenova Group
3.13.1 Aenova Group Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.13.3 Aenova Group Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.13.4 Aenova Group Business Overview
4 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Pharma Contract Manufacturing Organisations (Cmos) Production and Market Share by Type (2014-2019)
4.2 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue and Market Share by Type (2014-2019)
4.3 Global Pharma Contract Manufacturing Organisations (Cmos) Price by Type (2014-2019)
4.4 Global Pharma Contract Manufacturing Organisations (Cmos) Production Growth Rate by Type (2014-2019)
4.4.1 Global Pharma Contract Manufacturing Organisations (Cmos) Production Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing (2014-2019)
4.4.2 Global Pharma Contract Manufacturing Organisations (Cmos) Production Growth Rate of Finished Dosage Formulation (FDF) Market (2014-2019)
5 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) MARKET ANALYSIS BY APPLICATION
5.1 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption and Market Share by Application (2014-2019)
5.2 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Growth Rate of Pharma company (2014-2019)
5.2.2 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Growth Rate of Biotech company (2014-2019)
6 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption by Region (2014-2019)
6.2 United States Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export, Import (2014-2019)
6.3 Europe Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export, Import (2014-2019)
6.4 China Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export, Import (2014-2019)
6.5 Japan Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export, Import (2014-2019)
6.6 India Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export, Import (2014-2019)
7 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Pharma Contract Manufacturing Organisations (Cmos) Production and Market Share by Region (2014-2019)
7.2 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
8 PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) MANUFACTURING ANALYSIS
8.1 Pharma Contract Manufacturing Organisations (Cmos) Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Pharma Contract Manufacturing Organisations (Cmos)
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Pharma Contract Manufacturing Organisations (Cmos) Industrial Chain Analysis
9.2 Raw Materials Sources of Pharma Contract Manufacturing Organisations (Cmos) Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Pharma Contract Manufacturing Organisations (Cmos)
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) MARKET FORECAST (2019-2026)
11.1 Global Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue Forecast (2019-2026)
11.1.1 Global Pharma Contract Manufacturing Organisations (Cmos) Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Pharma Contract Manufacturing Organisations (Cmos) Price and Trend Forecast (2019-2026)
11.2 Global Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Pharma Contract Manufacturing Organisations (Cmos)
1.2 Pharma Contract Manufacturing Organisations (Cmos) Segment by Type
1.2.1 Global Pharma Contract Manufacturing Organisations (Cmos) Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Active Pharmaceutical Ingredient (API) Manufacturing
1.2.3 The Market Profile of Finished Dosage Formulation (FDF) Market
1.3 Global Pharma Contract Manufacturing Organisations (Cmos) Segment by Application
1.3.1 Pharma Contract Manufacturing Organisations (Cmos) Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Pharma company
1.3.3 The Market Profile of Biotech company
1.4 Global Pharma Contract Manufacturing Organisations (Cmos) Market by Region (2014-2026)
1.4.1 Global Pharma Contract Manufacturing Organisations (Cmos) Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.3 Europe Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.3.1 Germany Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.3.2 UK Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.3.3 France Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.3.4 Italy Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.3.5 Spain Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.3.6 Russia Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.3.7 Poland Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.4 China Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.5 Japan Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.6 India Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.8 Central and South America Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Pharma Contract Manufacturing Organisations (Cmos) (2014-2026)
1.5.1 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue Status and Outlook (2014-2026)
1.5.2 Global Pharma Contract Manufacturing Organisations (Cmos) Production Status and Outlook (2014-2026)
2 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) MARKET LANDSCAPE BY PLAYER
2.1 Global Pharma Contract Manufacturing Organisations (Cmos) Production and Share by Player (2014-2019)
2.2 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue and Market Share by Player (2014-2019)
2.3 Global Pharma Contract Manufacturing Organisations (Cmos) Average Price by Player (2014-2019)
2.4 Pharma Contract Manufacturing Organisations (Cmos) Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Pharma Contract Manufacturing Organisations (Cmos) Market Competitive Situation and Trends
2.5.1 Pharma Contract Manufacturing Organisations (Cmos) Market Concentration Rate
2.5.2 Pharma Contract Manufacturing Organisations (Cmos) Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Almac Group
3.1.1 Almac Group Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.1.3 Almac Group Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.1.4 Almac Group Business Overview
3.2 Boehringer Ingelheim
3.2.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.2.3 Boehringer Ingelheim Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.2.4 Boehringer Ingelheim Business Overview
3.3 Patheon Inc.
3.3.1 Patheon Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.3.3 Patheon Inc. Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.3.4 Patheon Inc. Business Overview
3.4 WuXi AppTec
3.4.1 WuXi AppTec Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.4.3 WuXi AppTec Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.4.4 WuXi AppTec Business Overview
3.5 Grifols International, S.A
3.5.1 Grifols International, S.A Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.5.3 Grifols International, S.A Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.5.4 Grifols International, S.A Business Overview
3.6 Lonza AG
3.6.1 Lonza AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.6.3 Lonza AG Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.6.4 Lonza AG Business Overview
3.7 Vetter
3.7.1 Vetter Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.7.3 Vetter Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.7.4 Vetter Business Overview
3.8 Pharmaceutical Product Development
3.8.1 Pharmaceutical Product Development Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.8.3 Pharmaceutical Product Development Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.8.4 Pharmaceutical Product Development Business Overview
3.9 AbbVie Inc
3.9.1 AbbVie Inc Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.9.3 AbbVie Inc Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.9.4 AbbVie Inc Business Overview
3.10 CMIC Group
3.10.1 CMIC Group Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.10.3 CMIC Group Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.10.4 CMIC Group Business Overview
3.11 Nectar Lifesciences
3.11.1 Nectar Lifesciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.11.3 Nectar Lifesciences Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.11.4 Nectar Lifesciences Business Overview
3.12 Catalant
3.12.1 Catalant Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.12.3 Catalant Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.12.4 Catalant Business Overview
3.13 Aenova Group
3.13.1 Aenova Group Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
3.13.3 Aenova Group Pharma Contract Manufacturing Organisations (Cmos) Market Performance (2014-2019)
3.13.4 Aenova Group Business Overview
4 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Pharma Contract Manufacturing Organisations (Cmos) Production and Market Share by Type (2014-2019)
4.2 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue and Market Share by Type (2014-2019)
4.3 Global Pharma Contract Manufacturing Organisations (Cmos) Price by Type (2014-2019)
4.4 Global Pharma Contract Manufacturing Organisations (Cmos) Production Growth Rate by Type (2014-2019)
4.4.1 Global Pharma Contract Manufacturing Organisations (Cmos) Production Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing (2014-2019)
4.4.2 Global Pharma Contract Manufacturing Organisations (Cmos) Production Growth Rate of Finished Dosage Formulation (FDF) Market (2014-2019)
5 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) MARKET ANALYSIS BY APPLICATION
5.1 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption and Market Share by Application (2014-2019)
5.2 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Growth Rate of Pharma company (2014-2019)
5.2.2 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Growth Rate of Biotech company (2014-2019)
6 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption by Region (2014-2019)
6.2 United States Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export, Import (2014-2019)
6.3 Europe Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export, Import (2014-2019)
6.4 China Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export, Import (2014-2019)
6.5 Japan Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export, Import (2014-2019)
6.6 India Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export, Import (2014-2019)
7 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Pharma Contract Manufacturing Organisations (Cmos) Production and Market Share by Region (2014-2019)
7.2 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue, Price and Gross Margin (2014-2019)
8 PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) MANUFACTURING ANALYSIS
8.1 Pharma Contract Manufacturing Organisations (Cmos) Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Pharma Contract Manufacturing Organisations (Cmos)
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Pharma Contract Manufacturing Organisations (Cmos) Industrial Chain Analysis
9.2 Raw Materials Sources of Pharma Contract Manufacturing Organisations (Cmos) Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Pharma Contract Manufacturing Organisations (Cmos)
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) MARKET FORECAST (2019-2026)
11.1 Global Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue Forecast (2019-2026)
11.1.1 Global Pharma Contract Manufacturing Organisations (Cmos) Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Pharma Contract Manufacturing Organisations (Cmos) Price and Trend Forecast (2019-2026)
11.2 Global Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Pharma Contract Manufacturing Organisations (Cmos) Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Pharma Contract Manufacturing Organisations (Cmos) Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
